Zhan W, Liao X, Tian T, Zhang RY, Li P, Wu XP, et al. Perianal multiple Bowen's disease: a case report. Int J Clin Exp Pathol. 2015. 8 (11):15039-41. [QxMD MEDLINE Link]. [Full Text].
Kossard S, Rosen R. Cutaneous Bowen's disease. An analysis of 1001 cases according to age, sex, and site. J Am Acad Dermatol. 1992 Sep. 27(3):406-10. [QxMD MEDLINE Link].
Shannon RL, Strayer DS. Arsenic-induced skin toxicity. Hum Toxicol. 1989 Mar. 8(2):99-104. [QxMD MEDLINE Link].
Hunt KM, Srivastava RK, Elmets CA, Athar M. The mechanistic basis of arsenicosis: Pathogenesis of skin cancer. Cancer Lett. 2014 Aug 27. [QxMD MEDLINE Link].
Derancourt C, Mougin C, Chopard Lallier M, Coumes-Marquet S, Drobacheff C, Laurent R. [Oncogenic human papillomaviruses in extra-genital Bowen disease revealed by in situ hybridization]. Ann Dermatol Venereol. 2001 Jun-Jul. 128(6-7):715-8. [QxMD MEDLINE Link].
McKee P, Calonje E, Granter S. Tumors of the surface epithelium. Pathology of the Skin. 3rd. London: Elsevier Mosby; 2005. 2: 1193-1197.
Shim WH, Park HJ, Kim HS, et al. Bowenoid Papulosis of the Vulva and Subsequent Periungual Bowen's Disease Induced by the Same Mucosal HPVs. Ann Dermatol. 2011 Nov. 23(4):493-6. [QxMD MEDLINE Link]. [Full Text].
Euvrard S, Chardonnet Y, Pouteil-Noble C, et al. Association of skin malignancies with various and multiple carcinogenic and noncarcinogenic human papillomaviruses in renal transplant recipients. Cancer. 1993 Oct 1. 72(7):2198-206. [QxMD MEDLINE Link].
Drake AL, Walling HW. Variations in presentation of squamous cell carcinoma in situ (Bowen's disease) in immunocompromised patients. J Am Acad Dermatol. 2008 Jul. 59(1):68-71. [QxMD MEDLINE Link].
Chute CG, Chuang TY, Bergstralh EJ, Su WP. The subsequent risk of internal cancer with Bowen's disease. A population-based study. JAMA. 1991 Aug 14. 266(6):816-9. [QxMD MEDLINE Link].
Reizner GT, Chuang TY, Elpern DJ, Stone JL, Farmer ER. Bowen's disease (squamous cell carcinoma in situ) in Kauai, Hawaii. A population-based incidence report. J Am Acad Dermatol. 1994 Oct. 31(4):596-600. [QxMD MEDLINE Link].
Gupta S, Nutan, Dogra S, Kanwar AJ. Bowen Disease over photoprotected site in an Indian male. Dermatol Online J. 2009 Oct 15. 15(10):16. [QxMD MEDLINE Link].
Kovacs A, Yonemoto K, Katsuoka K, Nishiyama S, Harhai I. Bowen's disease: statistical study of a 10 year period. J Dermatol. 1996 Apr. 23(4):267-74. [QxMD MEDLINE Link].
[Guideline] Morton CA, Birnie AJ, Eedy DJ. British Association of Dermatologists' guidelines for the management of squamous cell carcinoma in situ (Bowen's disease) 2014. Br J Dermatol. 2014 Feb. 170(2):245-60. [QxMD MEDLINE Link].
Arbesman H, Ransohoff DF. Is Bowen's disease a predictor for the development of internal malignancy? A methodological critique of the literature. JAMA. 1987 Jan 23-30. 257(4):516-8. [QxMD MEDLINE Link].
Graham JH, Helwig EB. Bowen's disease and its relationship to systemic cancer. AMA Arch Derm. 1959 Aug. 80(2):133-59. [QxMD MEDLINE Link].
Jaeger AB, Gramkow A, Hjalgrim H, Melbye M, Frisch M. Bowen disease and risk of subsequent malignant neoplasms: a population-based cohort study of 1147 patients. Arch Dermatol. 1999 Jul. 135(7):790-3. [QxMD MEDLINE Link].
Poole S, Fenske NA. Cutaneous markers of internal malignancy. II. Paraneoplastic dermatoses and environmental carcinogens. J Am Acad Dermatol. 1993 Feb. 28(2 Pt 1):147-64. [QxMD MEDLINE Link].
Jaeger AB, Gramkow A, Hjalgrim H, Melbye M, Frisch M. Bowen disease and risk of subsequent malignant neoplasms: a population-based cohort study of 1147 patients. Arch Dermatol. 1999 Jul. 135(7):790-3. [QxMD MEDLINE Link].
Boer-Auer A, Jones M, Lyasnichaya OV. Cytokeratin 10-negative nested pattern enables sure distinction of clonal seborrheic keratosis from pagetoid Bowen's disease. J Cutan Pathol. 2012 Feb. 39(2):225-33. [QxMD MEDLINE Link].
Terada T. Pigmented Bowen disease arising in pigmented reticulated seborrheic keratosis. Int J Clin Oncol. 2010 Dec. 15(6):608-10. [QxMD MEDLINE Link].
Jung SE, Kim SK, Kim YC. Photodynamic therapy in Bowen disease of the first web space of the hand. Ann Dermatol. 2015 Feb. 27 (1):76-8. [QxMD MEDLINE Link].
Perruchoud DL, Varonier C, Haneke E, Hunger RE, Beltraminelli H, Borradori L, et al. Bowen disease of the nail unit: a retrospective study of 12 cases and their association with human papillomaviruses. J Eur Acad Dermatol Venereol. 2016 Sep. 30 (9):1503-6. [QxMD MEDLINE Link].
Saxena A, Kasper DA, Campanelli CD, Lee JB, Humphreys TR, Webster GF. Pigmented Bowen's disease clinically mimicking melanoma of the nail. Dermatol Surg. 2006 Dec. 32(12):1522-5. [QxMD MEDLINE Link].
Kalegowda IY, Böer-Auer A. Clonal Seborrheic Keratosis Versus Pagetoid Bowen Disease: Histopathology and Role of Adjunctive Markers. Am J Dermatopathol. 2017 Jun. 39 (6):433-439. [QxMD MEDLINE Link].
Boer-Auer A, Jones M, Lyasnichaya OV. Cytokeratin 10-negative nested pattern enables sure distinction of clonal seborrheic keratosis from pagetoid Bowen's disease. J Cutan Pathol. 2012 Feb. 39(2):225-33. [QxMD MEDLINE Link].
Fernandez-Flores A. Cytokeratin 17 immunoexpression in actinic keratosis (bowenoid and nonbowenoid) and in Bowen disease. Ann Diagn Pathol. 2016 Feb. 20:1-6. [QxMD MEDLINE Link].
Idriss MH, Misri R, Böer-Auer A. Orthokeratotic Bowen disease: a histopathologic, immunohistochemical and molecular study. J Cutan Pathol. 2016 Jan. 43 (1):24-31. [QxMD MEDLINE Link].
Bargman H, Hochman J. Topical treatment of Bowen's disease with 5-Fluorouracil. J Cutan Med Surg. 2003 Mar-Apr. 7(2):101-5. [QxMD MEDLINE Link].
Fulton JE Jr, Carter DM, Hurley HJ. Treatment of Bowen's disease with topical 5-fluorouracil under occlusion. Arch Dermatol. 1968 Feb. 97(2):178-80. [QxMD MEDLINE Link].
Sturm HM. Bowen's disease and 5-fluorouracil. J Am Acad Dermatol. 1979 Dec. 1(6):513-22. [QxMD MEDLINE Link].
Welch ML, Grabski WJ, McCollough ML, et al. 5-fluorouracil iontophoretic therapy for Bowen's disease. J Am Acad Dermatol. 1997 Jun. 36(6 Pt 1):956-8. [QxMD MEDLINE Link].
Mackenzie-Wood A, Kossard S, de Launey J, Wilkinson B, Owens ML. Imiquimod 5% cream in the treatment of Bowen's disease. J Am Acad Dermatol. 2001 Mar. 44(3):462-70. [QxMD MEDLINE Link].
van Egmond S, Hoedemaker C, Sinclair R. Successful treatment of perianal Bowen's disease with imiquimod. Int J Dermatol. 2007 Mar. 46(3):318-9. [QxMD MEDLINE Link].
Alessi SS, Sanches JA, de Oliveira WR, Messina MC, Pimentel ER, Festa Neto C. Treatment of cutaneous tumors with topical 5% imiquimod cream. Clinics (Sao Paulo). 2009. 64(10):961-6. [QxMD MEDLINE Link]. [Full Text].
Imiquimod for superficial and in situ skin malignancy. Drug Ther Bull. 2009 Oct. 47(10):113-6. [QxMD MEDLINE Link].
Fernandez-Vozmediano J, Armario-Hita J. Infiltrative squamous cell carcinoma on the scalp after treatment with 5% imiquimod cream. J Am Acad Dermatol. 2005 Apr. 52(4):716-7. [QxMD MEDLINE Link].
Dupree MT, Kiteley RA, Weismantle K, Panos R, Johnstone PA. Radiation therapy for Bowen's disease: lessons for lesions of the lower extremity. J Am Acad Dermatol. 2001 Sep. 45(3):401-4. [QxMD MEDLINE Link].
Anna Z, John K, Maria T, et al. The potential role of radiation therapy in Bowen's disease: a review of the current literature. Rev Recent Clin Trials. 2012 Feb. 7(1):42-6. [QxMD MEDLINE Link].
[Guideline] Braathen LR, Szeimies RM, Basset-Seguin N, et al. Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005. J Am Acad Dermatol. 2007 Jan. 56(1):125-43. [QxMD MEDLINE Link].
Jones CM, Mang T, Cooper M, Wilson BD, Stoll HL Jr. Photodynamic therapy in the treatment of Bowen's disease. J Am Acad Dermatol. 1992 Dec. 27(6 Pt 1):979-82. [QxMD MEDLINE Link].
O'Connell KA, Okhovat JP, Zeitouni NC. Photodynamic therapy for Bowen's Disease (squamous cell carcinoma in situ) current review and update. Photodiagnosis Photodyn Ther. 2018 Dec. 24:109-114. [QxMD MEDLINE Link].
[Guideline] Christensen E, Warloe T, Kroon S, et al. Guidelines for practical use of MAL-PDT in non-melanoma skin cancer. J Eur Acad Dermatol Venereol. 2010 May. 24 (5):505-12. [QxMD MEDLINE Link].
Ferrandiz L, Ruiz-de-Casas A, Trakatelli M, et al. Assessing physicians' preferences on skin cancer treatment in Europe. Br J Dermatol. 2012 Aug. 167 Suppl 2:29-35. [QxMD MEDLINE Link].
Cleary RK, Schaldenbrand JD, Fowler JJ, Schuler JM, Lampman RM. Treatment options for perianal Bowen's disease: survery of American Society of Colon and Rectal Surgeons Members. Am Surg. 2000 Jul. 66(7):686-8. [QxMD MEDLINE Link].
Leibovitch I, Huilgol SC, Selva D, Richards S, Paver R. Cutaneous squamous carcinoma in situ (Bowen's disease): treatment with Mohs micrographic surgery. J Am Acad Dermatol. 2005 Jun. 52(6):997-1002. [QxMD MEDLINE Link].
Tantikun N. Treatment of Bowen's disease of the digit with carbon dioxide laser. J Am Acad Dermatol. 2000 Dec. 43(6):1080-3. [QxMD MEDLINE Link].
Neubert T, Lehmann P. Bowen's disease - a review of newer treatment options. Ther Clin Risk Manag. 2008 Oct. 4(5):1085-95. [QxMD MEDLINE Link]. [Full Text].
Moreno G, Chia AL, Lim A, Shumack S. Therapeutic options for Bowen's disease. Australas J Dermatol. 2007 Feb. 48(1):1-8; quiz 9-10. [QxMD MEDLINE Link].
Mun JH, Park JM, Song M, et al. The use of dermatoscopy to monitor therapeutic response of Bowen disease: a dermatoscopic pathological study. Br J Dermatol. 2012 Dec. 167(6):1382-5. [QxMD MEDLINE Link].
Arnold HL, Odom RB, James WD. Bowen's disease. Arnold HL, Andrews GC, Odom RB, James WB, eds. Andrews' Diseases of the Skin. 8th ed. Philadelphia, Pa: WB Saunders; 1990. 783-5.